These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 17413011)

  • 1. Alzheimer amyloid beta-peptide A-beta25-35 blocks adenylate cyclase-mediated forms of hippocampal long-term potentiation.
    Bisel BE; Henkins KM; Parfitt KD
    Ann N Y Acad Sci; 2007 Feb; 1097():58-63. PubMed ID: 17413011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo.
    Jing W; Guo F; Cheng L; Zhang JF; Qi JS
    Neurosci Lett; 2009 Feb; 450(3):306-10. PubMed ID: 19059464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase C mediates amyloid beta-protein fragment 31-35-induced suppression of hippocampal late-phase long-term potentiation in vivo.
    Zhang JF; Qi JS; Qiao JT
    Neurobiol Learn Mem; 2009 Mar; 91(3):226-34. PubMed ID: 19061963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of impairment of long-term potentiation by amyloid beta is independent of NMDA receptors or voltage-dependent calcium channels in hippocampal CA1 pyramidal neurons.
    Nomura I; Kato N; Kita T; Takechi H
    Neurosci Lett; 2005 Dec; 391(1-2):1-6. PubMed ID: 16154266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha7 Nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal LTP induction in beta-amyloid infused rats.
    Chen L; Yamada K; Nabeshima T; Sokabe M
    Neuropharmacology; 2006 Feb; 50(2):254-68. PubMed ID: 16324726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
    Trinchese F; Liu S; Battaglia F; Walter S; Mathews PM; Arancio O
    Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid beta-peptide Abeta(1-42) but not Abeta(1-40) attenuates synaptic AMPA receptor function.
    Parameshwaran K; Sims C; Kanju P; Vaithianathan T; Shonesy BC; Dhanasekaran M; Bahr BA; Suppiramaniam V
    Synapse; 2007 Jun; 61(6):367-74. PubMed ID: 17372971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.
    Shemer I; Holmgren C; Min R; Fülöp L; Zilberter M; Sousa KM; Farkas T; Härtig W; Penke B; Burnashev N; Tanila H; Zilberter Y; Harkany T
    Eur J Neurosci; 2006 Apr; 23(8):2035-47. PubMed ID: 16630051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in beta-amyloid rat model of Alzheimer's disease.
    Srivareerat M; Tran TT; Alzoubi KH; Alkadhi KA
    Biol Psychiatry; 2009 Jun; 65(11):918-26. PubMed ID: 18849021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of IL-1 receptor antagonist on beta amyloid mediated depression of LTP in the rat CA1 in vivo.
    Schmid AW; Lynch MA; Herron CE
    Hippocampus; 2009 Jul; 19(7):670-6. PubMed ID: 19115392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulus pattern dependence of the Alzheimer's disease amyloid-beta 42 peptide's inhibition of long term potentiation in mouse hippocampal slices.
    Smith JP; Lal V; Bowser D; Cappai R; Masters CL; Ciccotosto GD
    Brain Res; 2009 May; 1269():176-84. PubMed ID: 19302985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus.
    Chen QS; Wei WZ; Shimahara T; Xie CW
    Neurobiol Learn Mem; 2002 May; 77(3):354-71. PubMed ID: 11991763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid beta-protein fragments 25-35 and 31-35 potentiate long-term depression in hippocampal CA1 region of rats in vivo.
    Cheng L; Yin WJ; Zhang JF; Qi JS
    Synapse; 2009 Mar; 63(3):206-14. PubMed ID: 19072840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid beta prevents activation of calcium/calmodulin-dependent protein kinase II and AMPA receptor phosphorylation during hippocampal long-term potentiation.
    Zhao D; Watson JB; Xie CW
    J Neurophysiol; 2004 Nov; 92(5):2853-8. PubMed ID: 15212428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of S14G-humanin against beta-amyloid induced LTP inhibition in mouse hippocampal slices.
    Zhang W; Miao J; Hao J; Li Z; Xu J; Liu R; Cao F; Wang R; Chen J; Li Z
    Peptides; 2009 Jun; 30(6):1197-202. PubMed ID: 19463756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic nicotine restores normal Aβ levels and prevents short-term memory and E-LTP impairment in Aβ rat model of Alzheimer's disease.
    Srivareerat M; Tran TT; Salim S; Aleisa AM; Alkadhi KA
    Neurobiol Aging; 2011 May; 32(5):834-44. PubMed ID: 19464074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid beta-protein fragment 31-35 suppresses long-term potentiation in hippocampal CA1 region of rats in vivo.
    Zhang JM; Wu MN; Qi JS; Qiao JT
    Synapse; 2006 Sep; 60(4):307-13. PubMed ID: 16786537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related deficits in long-term potentiation are insensitive to hydrogen peroxide: coincidence with enhanced autophosphorylation of Ca2+/calmodulin-dependent protein kinase II.
    Watson JB; Khorasani H; Persson A; Huang KP; Huang FL; O'Dell TJ
    J Neurosci Res; 2002 Nov; 70(3):298-308. PubMed ID: 12391589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A beta 25-35-induced depression of long-term potentiation in area CA1 in vivo and in vitro is attenuated by verapamil.
    Freir DB; Costello DA; Herron CE
    J Neurophysiol; 2003 Jun; 89(6):3061-9. PubMed ID: 12611943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Arctic amyloid beta protein inhibits hippocampal long-term potentiation in vivo.
    Klyubin I; Walsh DM; Cullen WK; Fadeeva JV; Anwyl R; Selkoe DJ; Rowan MJ
    Eur J Neurosci; 2004 May; 19(10):2839-46. PubMed ID: 15147317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.